Granules India Limited (BSE: 532482, NSE: GRANULES), a fast-growing Indian pharmaceutical company, announced the successful closing of its acquisition of Senn Chemicals AG, a Swiss based Contract Development and Manufacturing Organization (CDMO) specialising in peptide development and manufacturing.

The acquisition marks a strategic milestone in Granules’ transformation into a science- and innovation-led organisation and extends its capabilities into the fast growing peptide therapeutics segment.

We advised Granules India on its acquisition of Senn Chemicals, guiding the company on all Swiss law aspects of the transaction.

You can read the official press release on Granules website.